Delivery Order SPE2DE24DA017-SPE2D626F5111
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order, valued at $3,300, is scheduled for completion by September 9, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $16,500 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 10, 2025, for the Arthrex ACP Double Syringe System. The delivery order, which carries an ultimate completion date of July 15, 2025, represents a non-competitive award with no set-aside designation. This delivery order is issued under Arthrex's existing Indefinite Delivery Contract...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $1,650 fixed-price delivery order with economic price adjustment from the Defense Logistics Agency's Medical Supply Chain on June 18, 2025. The contract calls for delivery of the Arthrex ACP Double Syringe System, an orthopedic surgical device, with final completion scheduled for June 24, 2025. This delivery order was awarded without a set-aside designation, reflecting Arthrex's competitive standing in the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $1,650 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 8, 2025, represents a task order issued under Arthrex's significant Indefinite Delivery Contract (IDC SPE2DE24D0020) valued at $471.0 million and spanning from June...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies, received a $3,300 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the Arthrex ACP Double Syringe System. The contract, which carries an ultimate completion date of September 3, 2025, represents a task order issued against Arthrex's substantial indefinite delivery contract with the Defense Logistics Agency valued at approximately $471...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., a leading developer and manufacturer of minimally invasive orthopedic medical technologies, received a delivery order valued at $3,025.44 from the Defense Logistics Agency's Medical Supply Chain on September 16, 2025. This fixed-price delivery order with economic price adjustment is scheduled for completion by September 19, 2025, and will be performed at the company's headquarters in Naples, Florida. The award utilized no set-aside designation, reflecting Arthrex's strong...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $4,356.00 for the Arthrex ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for completion by June 24, 2025, and represents a specific task order issued under Arthrex's larger indefinite delivery contract (SPE2DE24D0020) with the Defense...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F5111Delivery Order
Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a $3,300 delivery order for the Arthrex ACP Double Syringe System on October 27, 2025, with completion scheduled for November 10, 2025. The award carries fixed-price pricing with economic price adjustment terms and was issued without set-aside designation. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for supplying medical equipment and products to Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order is issued under Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, a comprehensive master contract valued at approximately $471 million and effective through September 1, 2029. The IDC authorizes procurement of Arthrex's full orthopedic product portfolio, including surgical implants, arthroscopic instruments, joint replacement technologies, and biologics supporting VA medical centers and military healthcare facilities nationwide. As a prime contractor with direct relationships to federal agencies, Arthrex has generated over $550,000 in delivery order activity under this vehicle through multiple Veterans Integrated Service Networks and demonstrates significant capability to meet the complex orthopedic healthcare requirements of the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 10/27/25 |